Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: Results of the international cross-sectional ASAS-COMOSPA study

Annals of the Rheumatic Diseases

Volumn 75, Issue 6, 2016, Pages 1016-1023

  Moltó, Anna ^a,b   Etcheto, Adrien ^a,b   Van Der Heijde, Désirée ^c   Landewé, Robert ^d   Van Den Bosch, Filip ^e   Bautista Molano, Wilson ^f   Burgos Vargas, Ruben ^g   Cheung, Peter P ^h   Collantes Estevez, Eduardo ⁱ   Deodhar, Atul ^j   El Zorkany, Bassel ^k   Erdes, Shandor ^l   Gu, Jieruo ^m   Hajjaj Hassouni, Najia ^n,o   Kiltz, Uta ^p   Kim, Tae Hwan ^q   Kishimoto, Mitsumasa ^r   Luo, Shue Fen ^s   Machado, Pedro M ^t,u   Maksymowych, Walter P ^v   Maldonado Cocco, José ^w   Marzo Ortega, Helena ^x   Montecucco, Carlo Maurizio ^y   Ozgoçmen, Salih ^z   Van Gaalen, Floris ^c   Dougados, Maxime ^a,b   more..

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b PARIS DESCARTES UNIVERSITY   (France)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Amsterdam and Atrium MC Heerlen   (Netherlands)

^e GHENT UNIVERSITY HOSPITAL   (Belgium)

^f UNIVERSIDAD MILITAR NUEVA GRANADA   (Colombia)

^g UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^h NATIONAL UNIVERSITY HOSPITAL   (Singapore)

ⁱ UNIVERSITY OF CÓRDOBA   (Spain)

^j OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^k CAIRO UNIVERSITY   (Egypt)

^l RUSSIAN ACADEMY OF SCIENCES   (Russian Federation)

^m THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

ⁿ Hopital El Ayachi   (Morocco)

^o MOHAMMED V UNIVERSITY   (Morocco)

^p RHEUMAZENTRUM RUHRGEBIET   (Germany)

^q Hanyang University Hospital for Rheumatic Diseases   (South Korea)

^r ST LUKE'S INTERNATIONAL UNIVERSITY   (Japan)

^s CHANG GUNG UNIVERSITY   (Taiwan)

^t UNIVERSITY OF COIMBRA   (Portugal)

^u UNIVERSITY COLLEGE LONDON   (United Kingdom)

^v UNIVERSITY OF ALBERTA   (Canada)

^w Argentine Rheumatologic Foundation Dr Osvaldo Carcia Morteo ^*  (Argentina)

^x UNIVERSITY OF LEEDS   (United Kingdom)

^y UNIVERSITY OF PAVIA   (Italy)

^z ERCIYES UNIVERSITY   (Turkey)

more..

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; COMORBIDITY; CROSS-SECTIONAL STUDY; ELEVATED BLOOD PRESSURE; FEMALE; GASTROINTESTINAL DISEASE; GERMANY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INFECTION; MAJOR CLINICAL STUDY; MALE; NEOPLASM; OBSERVATIONAL STUDY; OSTEOPOROSIS; PEPTIC ULCER; PREVALENCE; PRIORITY JOURNAL; SCREENING; SMOKING; SPONDYLARTHRITIS; TAIWAN; CARDIOVASCULAR DISEASES; COMMUNICABLE DISEASES; GASTROINTESTINAL DISEASES; MASS SCREENING; MIDDLE AGED; NEOPLASMS; PROCEDURES; RISK FACTOR; STATISTICS AND NUMERICAL DATA;

ADULT; CARDIOVASCULAR DISEASES; COMMUNICABLE DISEASES; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; NEOPLASMS; OSTEOPOROSIS; PREVALENCE; RISK FACTORS; SPONDYLARTHRITIS;

EID: 84962274738     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2015-208174     Document Type: Article

References (50)

1. Dougados M, Baeten D. Spondyloarthritis. Lancet 2011;377:2127-37.
2. Bremander A, Petersson IF, Bergman S, et al. Population-based estimates of common comorbidities and cardiovascular disease in ankylosing spondylitis. Arthritis Care Res 2011;63:550-6.
3. Prati C, Claudepierre P, Pham T, et al. Mortality in spondylarthritis. Jt Bone Spine Rev Rhum 2011;78:466-70.
4. Gladman DD. Mortality in psoriatic arthritis. Clin Exp Rheumatol 2008;26:S62-5.
5. Essers I, Stolwijk C, Boonen A, et al. Ankylosing spondylitis and risk of ischaemic heart disease: a population-based cohort study. Ann Rheum Dis 2016;75:203-9.
6. Sari I, Okan T, Akar S, et al. Impaired endothelial function in patients with ankylosing spondylitis. Rheumatology (Oxford) 2006;45:283-6.
7. Peters MJL, van Eijk IC, Smulders YM, et al. Signs of accelerated preclinical atherosclerosis in patients with ankylosing spondylitis. J Rheumatol 2010;37:161-6.
8. Mathieu S, Gossec L, Dougados M, et al. Cardiovascular profile in ankylosing spondylitis: a systematic review and meta-analysis. Arthritis Care Res 2011;63:557-63.
9. Briot K, Garnero P, Le Henanff A, et al. Body weight, body composition, and bone turnover changes in patients with spondyloarthropathy receiving anti-tumour necrosis factor {alpha} treatment. Ann Rheum Dis 2005;64:1137-40.
10. Westerveld LA, Verlaan JJ, Oner FC. Spinal fractures in patients with ankylosing spinal disorders: a systematic review of the literature on treatment, neurological status and complications. Eur Spine J Off Publ Eur Spine Soc Eur Spinal Deform Soc Eur Sect Cerv Spine Res Soc 2009;18:145-56.
11. Verlaan JJ, Diekerhof CH, Buskens E, et al. Surgical treatment of traumatic fractures of the thoracic and lumbar spine: a systematic review of the literature on techniques, complications, and outcome. Spine 2004;29:803-14.
12. Askling J, Klareskog L, Blomqvist P, et al. Risk for malignant lymphoma in ankylosing spondylitis: a nationwide Swedish case-control study. Ann Rheum Dis 2006;65:1184-7.
13. Feltelius N, Ekbom A, Blomqvist P. Cancer incidence among patients with ankylosing spondylitis in Sweden 1965-95: a population based cohort study. Ann Rheum Dis 2003;62:1185-8.
14. Fouque-Aubert A, Jette-Paulin L, Combescure C, et al. Serious infections in patients with ankylosing spondylitis with and without TNF blockers: a systematic review and meta-analysis of randomised placebo-controlled trials. Ann Rheum Dis 2010;69:1756-61.
15. Strobel ES, Fritschka E. Renal diseases in ankylosing spondylitis: review of the literature illustrated by case reports. Clin Rheumatol 1998;17:524-30.
16. Gratacos J, Orellana C, Sanmarti R, et al. Secondary amyloidosis in ankylosing spondylitis. A systematic survey of 137 patients using abdominal fat aspiration. J Rheumatol 1997;24:912-15.
17. Peters MJL, Symmons DPM, McCarey D, et al. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 2010;69:325-31.
18. van Assen S, Elkayam O, Agmon-Levin N, et al. Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseases. Autoimmun Rev 2011;10:341-52.
19. Soubrier M, Zerkak D, Dougados M. Indications for lowering LDL cholesterol in rheumatoid arthritis: an unrecognized problem. J Rheumatol 2006;33:1766-9.
20. Toms TE, Panoulas VF, Douglas KMJ, et al. Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatment of lipid-associated cardiovascular risk? Ann Rheum Dis 2010;69:683-8.
21. Dougados M, Soubrier M, Antunez A, et al. Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA). Ann Rheum Dis 2014;73:62-8.
22. Rudwaleit M, van der Heijde D, Landewé R, et al. The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 2011;70:25-31.
23. Garrett S, Jenkinson T, Kennedy LG, et al. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994;21:2286-91.
24. Lukas C, Landewé R, Sieper J, et al. Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis 2009;68:18-24.
25. van der Heijde D, Lie E, Kvien TK, et al. ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis 2009;68:1811-18.
26. Calin A, Garrett S, Whitelock H, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 1994;21:2281-5.
27. Haute Autorité de Santé - HAS - Accueil. http://www.has-sante.fr/portail/jcms/fc-1249588/fr/accueil (accessed 3 Feb 2015).
28. Choi BY, Fine JP, Brookhart MA. Practicable confidence intervals for current status data. Stat Med 2013;32:1419-28.
29. LES RHUMATISMES EN 100 questions. http://www.rhumatismes.net/index.php?p=1 (accessed 3 Feb 2015).
30. Haute Autorité de Santé - Dépistage du cancer du sein. http://www.has-sante.fr/portail/jcms/r-1501534/fr/depistage-du-cancer-du-sein?xtmc=&xtcr=5 (accessed 3 Feb 2015).
31. Haute Autorité de Santé - Dépistage du cancer du col de l'utérus en France. http://www.has-sante.fr/portail/jcms/c-1122010/fr/depistage-du-cancer-du-colde-l-uterus-en-france?xtmc=&xtcr=3 (accessed 3 Feb 2015).
32. Haute Autorité de Santé - Dépistage et prévention du cancer colorectal. http://www.has-sante.fr/portail/jcms/c-1623732/fr/depistage-et-preventiondu-cancer-colorectal (accessed 3 Feb 2015).
33. Recommandations | SNFGE.org - Société savante médicale française d'hépato-gastroentérologie et d'oncologie digestive. http://www.snfge.org/recommandations?field-reco-annee-value%5Bvalue%5D%5Byear%5D=&field-reco-themes-tid=2&field-reco-auteurs-tid=All&field-reco-type-tid=All&title= (accessed 27 Apr 2015).
34. Negredo E, Domingo P, Ferrer E, et al. Peak bone mass in young HIV-infected patients compared with healthy controls. J Acquir Immune Defic Syndr 2014;65:207-12.
35. El Maghraoui A, Borderie D, Cherruau B, et al. Osteoporosis, body composition, and bone turnover in ankylosing spondylitis. J Rheumatol 1999;26:2205-9.
36. Klingberg E, Lorentzon M, Mellström D, et al. Osteoporosis in ankylosing spondylitis -prevalence, risk factors and methods of assessment. Arthritis Res Ther 2012;14: R108.
37. van der Weijden MA, Claushuis TA, Nazari T, et al. High prevalence of low bone mineral density in patients within 10 years of onset of ankylosing spondylitis: a systematic review. Clin Rheumatol 2012;31:1529-35.
38. Briot K, Durnez A, Paternotte S, et al. Bone oedema on MRI is highly associated with low bone mineral density in patients with early inflammatory back pain: results from the DESIR cohort. Ann Rheum Dis 2013;72:1914-19.
39. Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Circulation 2015;131: e29-322.
40. ESC|About the ESC|What we do|European Affairs|EuroHeart|2012 European Cardiovascular Disease Statistics - Visuals. http://www.escardio.org/about/what/advocacy/EuroHeart/Pages/2012-european-cvd-statistics-visuals.aspx (accessed 17 Mar 2015).
41. Callow AD. Cardiovascular disease 2005-the global picture. Vascul Pharmacol 2006;45:302-7.
42. Quinn M, Babb P. Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: international comparisons. BJU Int 2002;90:162-73.
43. Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin 2015;65:87-108.
44. Globocan 2012 - Home. http://globocan.iarc.fr/Default.aspx (accessed 16 Mar 2015).
45. Goëb V, Ardizzone M, Arnaud L, et al. Recommendations for using TNFα antagonists and French Clinical Practice Guidelines endorsed by the French National Authority for Health. Jt Bone Spine Rev Rhum 2013;80:574-81.
46. Komenaka IK, Nodora JN, Hsu C-H, et al. Association of health literacy with adherence to screening mammography guidelines. Obstet Gynecol 2015;125:852-9.
47. Weinberg DS, Myers RE, Keenan E, et al. Genetic and environmental risk assessment and colorectal cancer screening in an average-risk population a randomized trial risk assessment and colorectal cancer screening. Ann Intern Med 2014;161:537-45.
48. Dehkordy SF, Hall KS, Roach AL, et al. Trends in breast cancer screening: impact of U.S.Preventive Services Task Force recommendations. Am J Prev Med 2015;49:419-22.
49. Palache A, Oriol-Mathieu V, Abelin A, et al. Seasonal influenza vaccine dose distribution in 157 countries (2004-2011). Vaccine 2014;32:6369-76.
50. Sadlier M, Sadlier C, Alani A, et al. Poor adherence to vaccination guidelines in dermatology patients on immunosuppressive therapies: an issue that needs addressing. Br J Dermatol 2015;173:288-9.